World News: 15:18 GMT Tuesday 3rd December 2019. [Research and Markets via Globe Newswire via SPi World News]
Dublin, Dec. 03, 2019 (GLOBE NEWSWIRE) -- The report has been added to offering.
The global infectious disease In Vitro Diagnostic (IVD) and Molecular Test market has increased significantly during the years 2017-2018 and projections are made that the market would rise in the next four years i.e. 2019-2023, tremendously.
The infectious disease In Vitro Diagnostic (IVD) and Molecular Test market is expected to increase due to growing geriatric population, rising affordability, increasing the prevalence of infectious diseases, escalating healthcare spending, growing preference of point-of-care diagnostics/testing, etc. Yet the market faces some challenges such as the high cost involved, stringent government regulations, etc.
The global infectious disease in vitro diagnostic (IVD) and molecular test market is highly fragmented with many infectious disease IVD and molecular test market players operating worldwide. Some infectious disease IVD and molecular test market players operating on a local level while other players operating on a regional and global level. Further, key players of the market are Roche, Abbott Laboratories, bioMerieux, Siemens Healthineers are also profiled with their financial information and respective business strategies.
For more information about this report visit
Research and Markets also offers services providing focused, comprehensive and tailored research.
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Globe Newswire: 15:18 GMT Tuesday 3rd December 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.